These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2256469)

  • 1. Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.
    Ponticelli C; Rivolta E
    Am J Nephrol; 1990; 10 Suppl 1():105-9. PubMed ID: 2256469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K
    Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
    Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
    Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
    Chan MK; Cheng IK
    Postgrad Med J; 1987 Sep; 63(743):757-9. PubMed ID: 3444800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.
    Meyrier A
    Springer Semin Immunopathol; 1987; 9(4):441-50. PubMed ID: 3324370
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclosporin in the treatment of nephrosis. Minimal change disease and focal-segmental glomerulosclerosis.
    Meyrier A
    Am J Nephrol; 1989; 9 Suppl 1():65-71. PubMed ID: 2646928
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclosporin in idiopathic nephrotic syndrome of children.
    Brodehl J; Hoyer PF
    Am J Nephrol; 1989; 9 Suppl 1():61-4. PubMed ID: 2923148
    [No Abstract]   [Full Text] [Related]  

  • 11. [Idiopathic Nephrotic Syndrome: recommendations of the Nephrology Branch of the Chilean Society of Pediatrics. Part One].
    Hevia P; Nazal V; Rosati MP; Quiroz L; Alarcón C; Márquez S; Cuevas K;
    Rev Chil Pediatr; 2015; 86(4):291-8. PubMed ID: 26362970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Mason PD
    J R Coll Physicians Lond; 1997; 31(2):137-41. PubMed ID: 9131509
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine in nephrotic syndrome.
    Ponticelli C; Rivolta E
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):253-8. PubMed ID: 3289208
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine treatment of nephrotic syndrome in children.
    Brodehl J; Hoyer PF; Oemar BS; Helmchen U; Wonigeit K
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):269-74. PubMed ID: 3381282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclosporin A in glomerular diseases].
    Brodehl J
    Internist (Berl); 1985 Sep; 26(9):578-9. PubMed ID: 3905681
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the nephrotic syndrome with cyclosporin A.
    Ponticelli C
    J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.
    Walker RG; Kincaid-Smith P
    Nephron; 1990; 54(2):117-21. PubMed ID: 2179754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.